Austem Company Ltd. Overview
Austem is a small-cap Korean tier-1 automotive metal-components supplier. Its core competence is stamping, welding and assembly of structural steel parts. It sells chassis modules (front and rear cross members, control arms, axles, suspension links), body-in-white structures (longitudinal frames, twist beams, panels, instrument-panel beams), steel wheels, and seat mechanisms (recliners and seat tracks). A legacy ceramics business adds silicon-carbide diesel particulate filters and catalysts. GM Korea is the anchor customer; Renault Korea, and historically Ssangyong and Hyundai, are secondary. Revenue has moved between roughly KRW 110 bn and KRW 142 bn a year since 2021, with thin and volatile margins. Earnings were badly damaged in FY2024 by a KRW 22.4 bn impairment of associate investments. On a trailing basis to June 2026, the company is profitable, holds net cash, has cancelled about 10% of its share count, and trades at about 0.4x book value. Its fortunes depend on GM Korea's export volumes to the United States.
What the company does
Austem makes structural and functional steel components for passenger vehicles. Its product families, as catalogued by MarkLines' supplier database, are:
Chassis and modules: front cross members, rear cross members, control-arm assemblies, axles and suspension links.
Body: front and rear longitudinal frames, twist beams, panels and instrument-panel (IP) beams.
Steel wheels: - Seat components: recliner cores, round recliner assemblies, power recliners, track cores and pumping devices.
Ceramics: SiC diesel particulate filter (DPF) systems; catalysts (three-way, diesel oxidation, catalysed DPF, SCR); and advanced ceramics (ceramic membrane filters and solid-oxide fuel-cell components).
Simply Wall St's company summary also lists alumina setter plates in the ceramics line. The 2024 KIRS/NICE D&B technology report describes the company as a maker of vehicle body, chassis, seat and steel-wheel parts plus DPF filters for vehicles and ships. It notes that the company runs stamping and assembly lines and has worked with advanced foreign firms on technology.
Business model and revenue model
The business model is classic build-to-specification automotive supply. Austem wins nomination on a vehicle program, tools up, and supplies parts over the program life against OEM production schedules. Revenue is effectively 100% product sales. No service, subscription or licensing revenue is disclosed.
Contract economics are visible in two disclosed GM awards:
GM Korea rear axle: total contract value KRW 47,617 mn, for September 2013 to December 2017. About KRW 11,500 mn (24.2%) had been delivered by the September 2014 disclosure [MarkLines, citing the company's 29-Sep-2014 release].
GM Indonesia front cradle and rear axle: total contract value KRW 25,987 mn, for August 2012 to December 2017. About KRW 4,600 mn (17.7%) had been delivered by the August 2015 disclosure [MarkLines, citing the company's 31-Aug-2015 release].
These figures show that program revenue is spread over 4–5 years and depends on the customer's actual vehicle volumes. A nomination is not a guaranteed revenue stream.
Value-chain position
Austem sits in tier 1 for GM Korea chassis and body structures, and in tier 1 or tier 2 for seat mechanisms. Seat mechanisms can be sold either to seat integrators or directly to OEMs, depending on the program. Its inputs are mainly steel coil and plate, so it carries steel-price pass-through exposure. Raw-material cost was KRW 35.6 bn in FY2025, about 28% of revenue (computed from the ValueLine cost breakdown). Downstream, its volumes are tied to a few vehicle platforms.
Customers and end-markets
| Customer | Relationship evidence |
|---|---|
| GM / GM Korea | GM supplier since August 2002; GM "Supplier of the Year" for 2007 (awarded April 2008); supplier to GM's Delta2 (Lacetti-successor) program from 2006 [MarkLines]. MarkLines identifies GM as the main customer |
| Renault Korea (formerly Renault Samsung) | Named, with GM Korea, as a principal customer in 2020 and 2025 press coverage [Dealsite 2020; SmartToday 2025] |
| SsangYong (now KG Mobility) | Began supplying seat functional parts for the Rodius in March 2004 [MarkLines] |
| Hyundai Motor | Began supplying seat functional parts for the Genesis sedan in December 2007 [MarkLines] |
| Shanghai GM and other China OEMs | Supplied via POS-Austem China JVs from 2008 [MarkLines; Jobkorea disclosure history] |
| Daimler Chrysler (historical) | Named in the company's corporate description on Jobkorea |
End-markets: passenger cars (mostly compact crossovers at GM Korea), with a smaller ceramics and emissions-control niche.
Independent characterization
Austem is a concentrated, sub-scale supplier. Its earnings power is set mainly by the utilization of GM Korea's Bupyeong and Changwon plants. Since 2023 those plants have run almost entirely on Chevrolet Trax and Trailblazer exports to the United States. In 2020, Dealsite reported that Austem had struggled to reach operating breakeven from 2018 because GM Korea and Renault Samsung were both weak. That pattern repeated in FY2021–FY2022, when operating results were negative. When GM Korea runs at full capacity (FY2023, and 1H 2026), Austem's revenue and margins recover sharply. When volumes slip (FY2024), operating profit nearly disappears. The company's own annual-report description could not be retrieved in its original wording; the characterization above draws on the KIRS/NICE D&B report and the MarkLines profile.
Strategy
Stated strategy. No investor-day material, medium-term plan or English annual report exists. The KIRS/NICE D&B report (2024) frames the company around:
-
lightweighting and high-strength steel for body parts;
-
maintaining stamping and assembly capability for core GM programs;
-
the ceramic emissions business as technical diversification.
Medium-term financial targets / guidance. None publicly disclosed.
ESG commitments. None disclosed.
Products & Services
Pricing is not publicly disclosed for any product. Supply is under OEM program contracts.
Chassis & Module
| Product | Description / function | Target customer | Flagship / evidence |
|---|---|---|---|
| Front cross member assembly | Welded steel subframe carrying front suspension and powertrain mounts | Passenger-car OEMs (GM Korea primary) | GM Indonesia "front cradle" contract (KRW 26.0 bn, 2012–2017) |
| Rear cross member assembly | Rear suspension subframe | OEMs | MarkLines catalog |
| Control arm assembly | Suspension link between wheel hub and subframe | OEMs | MarkLines catalog |
| Axle | Rear axle / torsion-beam type assemblies | GM Korea, GM Indonesia | GM Korea rear axle contract (KRW 47.6 bn, 2013–2017) |
| Suspension link | Ancillary suspension linkages | OEMs | MarkLines catalog |
Body (Body-in-White)
| Product | Description | Notes |
|---|---|---|
| Front longitudinal frames | Primary crash-load path members | MarkLines catalog |
| Rear longitudinal frames | Rear structural rails | MarkLines catalog |
| Twist beams | Rear twist-beam axle structures (overlap with chassis) | MarkLines catalog |
| Panels (incl. front/rear floor panels) | Stamped floor and body panels | MarkLines (Chinese-language profile lists front/rear floor panels) |
| IP beams | Cross-car beam behind the instrument panel | MarkLines catalog |
The KIRS/NICE D&B report notes that the company applies high-strength/lightweight technology to key body parts such as bumpers and centre pillars.
Steel Wheels
The founding product line, beginning with the Cheonan steel-wheel disc plant in 1990. Pressed and welded steel wheels for passenger cars. No model-level detail disclosed.
Seat Components
| Product | Description |
|---|---|
| Recliner cores | Core locking mechanism for seat-back angle adjustment |
| Round recliner assemblies | Continuous-engagement recliner units |
| Power recliners | Motorized recliner mechanisms |
| Track cores | Seat slide-rail cores |
| Pumping device | Seat height-adjust ratchet mechanism |
Origin: built through the ACM (2005) and Seatek (2006–2007) acquisitions, both merged into Austem in December 2013. Reference programs: SsangYong Rodius (2004) and Hyundai Genesis (2007). In 2020, Bodyfriend cited Austem's seat technology as the rationale for a massage-chair parts tie-up.
Ceramics (KhanCera)
| Product | Description | Application |
|---|---|---|
| SiC DPF system | Silicon-carbide wall-flow diesel particulate filters | Diesel vehicles; KIRS also cites marine DPFs |
| Catalysts: TWC, DOC, CDPF, SCR | Three-way, diesel oxidation, catalysed DPF and selective-catalytic-reduction catalysts | Gasoline and diesel emissions control |
| Ceramic membrane filters (CMF) | Porous ceramic filtration membranes | Industrial filtration |
| SOFC components | Solid-oxide fuel-cell ceramics | Fuel cells |
| Alumina setter plates | Kiln furniture for firing ceramics and electronics | Industrial |
Sources: MarkLines product catalog; Simply Wall St company summary; KIRS/NICE D&B (2024). Launch years and latest versions are not publicly disclosed for any product line.
Financial Narrative
Income statement — five-year summary
Sources: Butler (DART-derived) for FY2021–FY2024; AGM results disclosure for FY2025 (revenue 128,549 mn; operating income 4,148 mn; net income 803 mn). Margins computed.
Revenue CAGR FY2021–FY2025 (computed): about 3.3% a year.
FY2025 income statement detail and trailing twelve months
Sources: ValueLine consolidated income statement (FY2025 and TTM columns); EPS FY2025 from the AGM disclosure (KRW 37 consolidated; KRW 144 separate). Discrepancy: ValueLine shows FY2025 consolidated EPS of KRW 33.1 against KRW 37 in the AGM disclosure. The AGM figure is used as primary. ValueLine's own EBITDA field for FY2025 (KRW 5.5 bn) differs from the computed OP+D&A figure of KRW 7.4 bn; the computed figure is shown.
TTM earnings quality. About KRW 7.6 bn of TTM other non-operating income is classified "other". It coincides with Q1-2026 net income of KRW 8.4 bn against operating income of only KRW 2.7 bn [Chickstock, DART-based]. The nature of this gain was not identified in the sources reviewed. Investors should treat the trailing P/E of under 3x as resting partly on a likely non-recurring item.
Quarterly datapoint
Q1-2026 revenue rose 40.8% YoY [Chickstock, DART filing of 15-May-2026]. Q1-2025 revenue is back-calculated from that growth rate. The Q3-2026 quarterly report is due by 16-Nov-2026.
Balance sheet
Source: ValueLine consolidated balance sheet (DART-derived). FY2025 totals reconcile to the AGM disclosure (assets 131,603 mn; liabilities 65,311 mn; equity 66,292 mn). Net debt and working capital are computed. Borrowings exclude lease liabilities, which were about KRW 0.5–1.5 bn across the period.
Latest balance sheet (30-Jun-2026, KRW bn): total assets 146.25; cash 30.93; short-term financial assets 30.29; receivables 25.62; inventories 13.14; PP&E 30.76; associates 3.03; total liabilities 67.92; total borrowings 35.35 (short-term 32.33, current long-term 2.03, long-term 0.99); computed net cash 25.87; total equity 78.33; equity attributable to owners 79.15; BPS KRW 3,154.8 [ValueLine].
Cash flow: notes and sources
Source: ValueLine consolidated cash flow statement. Discrepancy: ValueLine's own "free cash flow" field shows KRW 2.40 bn for FY2025 and KRW 15.19 bn for TTM Jun-2026, which suggests a different definition. The table uses OCF minus capex. TTM to Sep-2025 operating cash flow was −KRW 6.66 bn, reflecting a KRW 23.4 bn receivables build in that window.
Ratio analysis
All computed on average balances from the tables above.
Commentary on trends, inflections and drivers
FY2021–FY2022: loss-making trough. Revenue held at KRW 111–113 bn, operating results were negative, and net losses exceeded KRW 12 bn each year. The FY2022 balance sheet was stretched. Short-term borrowings were KRW 62.8 bn, net debt was KRW 40.0 bn, and the current ratio was 1.15x. Assets held for sale of KRW 29.8 bn suggest a disposal programme was under way. Customer weakness, specifically GM Korea's post-2018 restructuring and Renault Samsung's decline, was the main driver. Dealsite reported in 2020 that Austem had been unable to reach breakeven since 2018.
FY2023: cyclical recovery. Revenue jumped 28% to KRW 142.0 bn and operating margin reached 7.0%. This coincided with GM Korea's sales rebound to about 465,000 units in 2023, from about 224,000 in 2021, driven by the new Trax and Trailblazer exports [Yonhap/Bernama]. Proceeds from the held-for-sale asset appear to have been used to cut short-term borrowings by about KRW 37 bn, taking the group to net cash.
FY2024: impairment shock. Revenue fell 9.9% and operating income almost vanished (KRW 0.4 bn). The headline net loss of KRW 39.0 bn came from below the operating line: TTM data show a KRW 22.4 bn impairment of associate investments plus about KRW 3.7 bn of other asset impairments. Associates collapsed from KRW 38.3 bn to KRW 0.8 bn on the balance sheet, and equity fell by KRW 37 bn. The impaired entity is not named in the sources reviewed. Given the history of POSCO-partnered China operations serving GM's China business, a China-related holding is a plausible candidate, but this is unconfirmed.
FY2025: stabilization. Revenue was flat (+0.5%), operating margin recovered to 3.2%, and net income was just positive. Cash rose to KRW 26.6 bn.
1H-2026: inflection. GM asked GM Korea to run both plants at full capacity to build 500,000 units in 2026, up from 460,826 in 2025 [Yonhap/Bernama, 3-Feb-2026]. Austem's Q1-2026 revenue rose 40.8% YoY, and TTM revenue reached a multi-year high of KRW 138.7 bn. TTM operating cash flow of KRW 31.9 bn built net cash to about KRW 25.9 bn by June 2026, around 82% of market capitalization.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Results by Segment and Revenue by Segment (%)
| Metric (KRW Bn) | FY2025 |
|---|---|
Consolidated revenue | 128.55 |
Separate (parent) revenue | 104.42 |
Implied subsidiary contribution net of eliminations (computed) | 24.13 |
Parent share of consolidated revenue (%) (computed) | 81.2 |
Metric (KRW Bn) | FY2025 |
Consolidated operating income | 4.15 |
Separate operating income | 2.68 |
Consolidated net income | 0.80 |
Separate net income | 3.63 |
Group Entities
| Entity | Country | Relationship / stake | Function |
|---|---|---|---|
POS-Austem Suzhou Automotive Co., Ltd. | China | Austem 80.1% / POSCO China affiliate 19.9% at formation | Chassis and body parts for Shanghai GM |
POS-Austem Yantai Automotive Co., Ltd. | China | 80.1% / 19.9% at formation | Production base for GM Shanghai orders |
POS-Austem Wuhan Automotive Co., Ltd. | China | 87% / 13%, later 92.35% / 7.65% after capital increase | Production base for GM Shanghai orders |
KhanCera Co., Ltd. | Korea | Subsidiary since Aug 2010 | SiC DPF and ceramics |
O'zauto-Austem LLC | Uzbekistan | Established Jan 2011 | Automotive parts |
Gill-Austem, LLC | USA | Established Aug 2014 | Not specified |
AUSTEM AMERICA Inc. | USA | Established Sep 2021 | Not specified |
AUSTEM ExT (formerly IB Materials) | Korea (presumed) | Renamed Jul 2023 | Not specified |
Income Statement and Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (KRW Bn) | 112.8 | 110.9 | 142.0 | 127.9 | 128.5 |
Operating income (KRW Bn) | -0.3 | -4.7 | 9.9 | 0.4 | 4.1 |
Net income (KRW Bn) | -12.3 | -13.7 | 7.4 | -39.0 | 0.8 |
Operating margin (%) | -0.3 | -4.2 | 7.0 | 0.3 | 3.2 |
Net margin (%) | -10.9 | -12.4 | 5.2 | -30.5 | 0.6 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansMargin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Revenue growth YoY (%) | -1.7 | 28.0 | -9.9 | 0.5 |
Income Statement and Per-Share Data
| Line item (KRW Bn) | FY2025 | TTM to Jun-2026 |
|---|---|---|
Revenue | 128.54 | 138.70 |
Cost of sales | 100.58 | 108.39 |
Gross profit | 27.96 | 30.31 |
SG&A | 23.81 | 22.51 |
of which R&D expense | 2.20 | 2.38 |
Operating income | 4.14 | 7.79 |
D&A (PP&E depreciation + intangible amortization) | 3.24 | 3.51 |
EBITDA (computed, OP + D&A) | 7.38 | 11.30 |
Net financial result | -0.04 | -0.33 |
Other non-operating income | 1.84 | 10.04 |
Other non-operating expense | 3.33 | 2.01 |
Associates / equity-method result | -0.79 | -1.02 |
Pre-tax income | 1.81 | 14.47 |
Income tax | 1.01 | 3.19 |
Net income | 0.80 | 11.28 |
Net income attributable to owners | 0.92 | 11.36 |
EPS, basic (KRW) | 37 | 407 |
Margin (%)
| Margin (%) | FY2025 | TTM to Jun-2026 |
|---|---|---|
Gross margin | 21.8 | 21.9 |
Operating margin | 3.2 | 5.6 |
EBITDA margin (computed) | 5.7 | 8.1 |
Net margin | 0.6 | 8.1 |
Income Statement
| Metric (KRW Bn) | Q1-2025 (computed) | Q1-2026 |
|---|---|---|
Revenue | 24.3 | 34.2 |
Operating income | — | 2.7 |
Net income | — | 8.4 |
Balance Sheet and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Total assets (KRW Bn) | 187.25 | 161.22 | 119.81 | 131.60 |
Current assets (KRW Bn) | 99.30 | 90.87 | 85.97 | 98.70 |
Cash and equivalents (KRW Bn) | 12.56 | 15.04 | 16.18 | 26.55 |
Short-term financial assets (KRW Bn) | 12.26 | 20.26 | 21.45 | 21.61 |
Trade receivables (KRW Bn) | 21.97 | 34.34 | 26.63 | 32.08 |
Inventories (KRW Bn) | 17.27 | 16.25 | 13.47 | 13.21 |
Assets held for sale (KRW Bn) | 29.83 | 0.00 | 0.00 | 0.17 |
Investments in associates / equity-related (KRW Bn) | 47.88 | 38.32 | 0.79 | 1.01 |
PP&E (KRW Bn) | 30.05 | 27.47 | 29.14 | 28.55 |
Goodwill and intangibles (KRW Bn) | 0.81 | 0.84 | 0.71 | 0.59 |
Total liabilities (KRW Bn) | 91.94 | 59.04 | 54.83 | 65.31 |
Current liabilities (KRW Bn) | 86.45 | 53.49 | 48.19 | 59.23 |
Short-term borrowings (KRW Bn) | 62.83 | 25.97 | 26.01 | 32.50 |
Current portion of long-term borrowings (KRW Bn) | 0.58 | 1.38 | 1.00 | 0.01 |
Long-term borrowings (KRW Bn) | 1.41 | 0.52 | 0.61 | 3.05 |
Total borrowings (KRW Bn) | 64.82 | 27.87 | 27.62 | 35.56 |
Net debt, negative = net cash (KRW Bn) | 40.00 | -7.43 | -10.01 | -12.60 |
Total equity (KRW Bn) | 95.31 | 102.18 | 64.97 | 66.29 |
Equity attributable to owners (KRW Bn) | 94.77 | 102.46 | 65.64 | 67.09 |
Working capital (KRW Bn) | 12.85 | 37.38 | 37.78 | 39.47 |
Book value per share (KRW) | 3,384.8 | 3,659.5 | 2,344.5 | 2,396.1 |
Cash Flow
| Item (KRW Bn) | FY2025 | TTM to Jun-2026 |
|---|---|---|
Operating cash flow | 9.62 | 31.86 |
Capex: PP&E | 2.93 | 5.01 |
Capex: intangibles | 0.00 | 0.46 |
Free cash flow (computed, OCF − capex) | 6.69 | 26.39 |
Investing cash flow (total) | -4.84 | -11.24 |
Financing cash flow (total) | 6.34 | -1.42 |
Dividends paid | 0.76 | 0.50 |
Treasury-share purchases | 0.32 | 0.10 |
Year/period-end cash | 26.55 | 30.93 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
ROE (%) | 7.5 | -46.7 | 1.2 |
ROA (%) | 4.2 | -27.8 | 0.6 |
Current ratio (x) | 1.70 | 1.78 | 1.67 |
Debt to equity (x) | 0.27 | 0.43 | 0.54 |
Liabilities to equity (%) | 57.8 | 84.4 | 98.5 |
Asset turnover (x) | 0.82 | 0.91 | 1.02 |
Additional FY2025 ratios (computed)
| Additional FY2025 ratios (computed) | Value |
|---|---|
Interest coverage (OP / interest expense of KRW 1.37 bn) | 3.0x |
Net debt / EBITDA | net cash; −1.7x |
Pre-tax ROIC (OP / [equity + borrowings − cash and short-term financial assets]) | about 7.7% |
Receivable days (trade receivables / revenue × 365) | about 91 |
Inventory days (inventory / COGS × 365) | about 48 |
Payable days (trade payables of KRW 8.55 bn / COGS × 365) | about 31 |
Cash conversion cycle | about 108 days |
TTM Jun-2026 ROE (ValueLine) | 14.35% |
Revenue by Region and Revenue by Region (%)
| Metric | FY2025 |
|---|---|
Parent (Korea) revenue, KRW Bn | 104.42 |
Subsidiaries net of eliminations (computed), KRW Bn | 24.13 |
Parent share (%) | 81.2 |
Share Price and Market Valuation
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Year-end share price (KRW) | 1,415 | 1,932 | 1,231 | 1,070 |
Year-end market cap (KRW Bn) | 39.6 | 54.1 | 34.5 | 30.0 |
Valuation Multiples
| Multiple | Austem | Hwashin | Daewon Sanup | Daewon Kang Up |
|---|---|---|---|---|
P/E TTM (x) | 2.77 | 3.60 | 3.01 | 3.47 |
P/B (x) | 0.40 | 0.42 | 0.34 | 0.41 |
Dividend yield (%) | 1.78 | 2.27 | 2.39 | 2.74 |
Per-Share Data and Dividends & Capital Returns
| Metric | FY2024 | FY2025 |
|---|---|---|
Dividend per share (KRW) | 30 | 20 |
Total dividend (KRW Bn) | 0.76 | 0.50 |
Analyst Conclusions
Management guidance. None publicly disclosed. Consensus. None. The forward view below rests on the customer's disclosed production plans.
Bull case
-
Volume leverage at full capacity. GM Korea is targeting 500,000 units in 2026, and Q1-2026 revenue rose 40.8%. If operating margin returns to the FY2023 level of 7% on revenue of about KRW 140 bn, operating income would be about KRW 10 bn, against an EV of about KRW 5.5 bn.
-
Asset backing and capital return. P/B is about 0.36x on Jun-2026 BPS, net cash is about 82% of market cap, 10% of shares were just cancelled, and a buyback trust is active. Korea's 2026 Commercial Act reforms structurally favour shareholder returns at sub-book companies.
-
Program continuity. GM's US$600 mn Korean retool explicitly supports next-generation Trax/Trailblazer production beyond 2028, extending visibility for an incumbent chassis and body supplier.
Bear case
-
Single-customer cliff. More than 85% of GM Korea's output goes to the US under a 15% tariff. GM's tariff burden of US$3–4 bn and the absence of an EV allocation leave a credible risk of program loss or downsizing after the current cycle.
-
Poor quality of earnings and disclosure. The FY2024 KRW 22.4 bn impairment and the unexplained KRW 7.6 bn TTM gain mean reported profits are an unreliable guide. Excluding the gain, normalized TTM net income is closer to KRW 4–5 bn.
-
Structural margin ceiling. Operating margin has exceeded 5% in only one of five years. Peers with greater scale and Hyundai-Kia exposure earn 5–7%, and Austem's 1.7% R&D intensity limits any move into EV or robotics categories.
Catalysts and monitorables (next 12 months)
-
Q3-2026 report (due 16-Nov-2026), especially whether operating margin holds above 5% at full GM Korea volume.
-
Disclosure of the nature of the 1H-2026 non-operating gain.
-
Size and execution of the buyback trust, and whether repurchased shares are cancelled within the statutory year.
-
Direction of the insider trading plans filed 14-Oct-2026.
-
Any Bodyfriend stake change or shift in stated intent.
-
GM's next-generation Trax/Trailblazer sourcing decisions and any GM Korea EV allocation.
-
Changes to US tariffs on Korean vehicles.
-
FY2026 dividend declaration (February 2027).
Analyst verdict
Austem is a classic deep-value, high-dependency micro-cap. On the numbers, the stock looks almost free. The KRW 31.4 bn market cap is largely covered by about KRW 26 bn of net cash, the shares trade at roughly a third of book value, and trailing earnings put the P/E below 3x. Management has started to act like a capital allocator: it kept the dividend through a loss year, cancelled a tenth of the share base, and opened a new buyback trust. The near-term operating backdrop is the best in years, because GM has asked its Korean plants to run flat out and Austem's Q1 revenue rose by two-fifths.
The discount exists for identifiable reasons. Almost all of Austem's economic exposure runs through one customer whose Korean operation now survives on two low-priced crossovers sold into a tariffed US market, with no EV in sight. The company's record on capital deployed outside its core is poor. A KRW 22 bn associate impairment destroyed more than a third of equity in FY2024, and the trailing profit includes a sizeable gain that the company has not explained in the sources available. Disclosure is thin, governance is founder-led with a family successor, and control is contested only gently by Bodyfriend.
The cash-backed floor limits the downside, provided the short-term financial assets are unencumbered, which needs to be verified in the notes. The upside depends on two things: proof that 2026 volumes deliver operating margins of 5–7% rather than one-off gains, and a disclosed share in GM's post-2028 programs. Until the Q3-2026 report confirms operating leverage and the company clarifies the non-operating items, Austem is best regarded as a balance-sheet-anchored special situation. It is not a compounding franchise, and position sizing should reflect binary customer risk.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Title | Tenure / status | Background | Born |
|---|---|---|---|---|
Kim Jung-woo (김정우) | Chairman, CEO, inside director | CEO since the 2005 name change era per disclosure history; re-elected 27-Mar-2026 for 3 years | Seoul National University (commerce); previously at Daewoo Motor and Korea's National Tax Service | Sep 1948 |
Kim Min-seok (김민석) | Co-CEO, inside director | Co-CEO since 22-Mar-2024 | Son of Kim Jung-woo; Chung-Ang University graduate | — |
Kong Tae-hyun (공태현) | Non-standing director | Re-elected 27-Mar-2026 for 3 years | Head of Business Strategy Office, Bodyfriend | Mar 1980 |
Yoo Young-sang (유영상) | Outside (independent) director | Re-elected 27-Mar-2026 for 3 years | Former professor, SNU College of Engineering; former outside director, Samsung Securities | Aug 1948 |
Kim Dong-hyo (김동효) | Former co-CEO | Resigned Mar 2024 | — | — |
“—” = not publicly disclosed.
Shareholding Trend
| Shareholder | Stake (%) at 31-Dec-2024 | Stake (%) at 31-Dec-2025 |
|---|---|---|
Kim Jung-woo and 1 related party | 14.83 | 14.83 |
Bodyfriend Co., Ltd. and 2 related parties | 12.07 | 12.77 |
Kim Sung-joong (individual) | 6.07 | 6.07 |
Competitive Landscape
Competitors by Segment
| Product area | Competitors | Notes |
|---|---|---|
Chassis modules / subframes | Hwashin (KOSPI 010690); Pyeong Hwa Industrial; global: Magna, Gestamp, Benteler, Martinrea | Hwashin is the leading chassis supplier within the Hyundai group (about 57% share of the group's chassis category per an AlphaDistill initiation) |
Body-in-white structures | Sungwoo Hitech; Hwashin; global: Gestamp, Magna | Sungwoo and Hwashin are described as the two major Korean chassis/body players [AlphaDistill] |
Seat mechanisms (recliners, tracks) | Daewon Sanup (KOSDAQ 005710); Daewon Kang Up (KOSPI 000430); Hyundai Transys; global: Adient, Brose, Forvia, Magna, Toyota Boshoku | Daewon Sanup is a seat maker supplying Kia; Daewon Kang Up makes springs and seats |
Steel wheels | Domestic and global steel-wheel makers | — |
SiC DPF / catalysts | NGK Insulators, Ibiden, Corning (substrates); global catalyst coaters | Austem/KhanCera is a niche participant |
Peer Comparison FY2025
| Company | Revenue | YoY growth (%) | Operating income | Operating margin (%) | Net income | Market cap | P/E (x) | P/B (x) |
|---|---|---|---|---|---|---|---|---|
Austem (031510) | 128.5 | 0.5 | 4.1 | 3.2 | 0.8 | 31.4 | 2.77 (TTM) | 0.40 |
Hwashin (010690) | 1,962.5 | 14.6 | 102.4 | 5.2 | 66.7 | 261.9 | 3.60 | 0.42 |
Daewon Sanup (005710) | 1,058.9 | 13.7 | 70.8 | 6.7 | 76.9 | 210.0 | 3.01 | 0.34 |
Daewon Kang Up (000430) | 1,599.1 | 16.9 | 47.0 | 2.9 | 46.0 | 248.6 | 3.47 | 0.41 |
Recent Developments
Entries marked "context" are customer or industry events that directly affect Austem's volumes.



